LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

LifeMD, Inc.NASDAQ: LFMD

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development declines year over year

Q1 FY2026 research & development of $121.21K fell 95.5% year over year, behind the -25.4% change in trailing-twelve-month research & development. Sequentially, it fell 93.3% from the prior quarter. Over 3 fiscal years it compounded at +35.2% a year.

Context

  • Research & development amounted to 3.8% of revenue in FY2025, down 0.7 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -95.5% toward the trailing-twelve-month pace of -25.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$121.21K-93.3% QoQ
Last fiscal yearDec 2025
$7.35M-22.8% YoY
LTMMar 2026
$7.53M-25.4% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-95.5%——
1 year-22.8%——
3-year CAGR+35.2%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
7.35M USD
Year-over-year change
-22.8%
4-year CAGR
+66.8%

Research & Development vs competitors

How LFMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -25.4% is the 8th highest of 9, against a peer median of -10.7%.
  • Research & development amounts to 3.4% of revenue for LFMD, versus a peer median of 16.0%.
LFMD Competitors
Research & Development for LFMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CERSCerus CorporationLTM Mar 2026$65.65M USD+7.6%+0.8%29.5%
TBRGTruBridge, Inc.LTM Mar 2026$39.88M USD+24.6%+1.7%11.5%
SENSSenseonics Holdings, Inc.LTM Mar 2026$32.9M USD-13.4%-7.3%80.8%
MASS908 Devices Inc.LTM Mar 2026$13.97M USD-23.1%-7.7%24.2%
SGHTSight Sciences, Inc.LTM Mar 2026$12.72M USD-28.5%-13.9%16.0%
CVRXCVRx, Inc.LTM Mar 2026$11.7M USD+10.5%+3.8%19.8%
LFMDLifeMD, Inc.LTM Mar 2026$7.53M USD-25.4%+35.2%3.4%
SMTISanara MedTech Inc.LTM Mar 2026$5.08M USD-13.4%+14.6%4.7%
TKNOAlpha Teknova, Inc.LTM Mar 2026$2.25M USD-8.0%-34.3%5.4%
HITIHigh Tide Inc.LTM Apr 2026CA$0 CAD——0.0%
Peer median (excluding LFMD) —-10.7%-3.3%16.0%

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue92.88M119.03M152.55M212.45M194.06M
Cost of Revenue18M18.67M18.9M24.07M39.29M
Gross Profit74.88M100.37M133.65M188.39M154.76M
Gross Margin80.6%84.3%87.6%88.7%79.8%
Research & Development948.16K2.97M6.06M9.51M7.35M
Selling, General & Admin122.08M125.33M128.15M175.68M144.01M
Operating Expenses129.18M143.81M148.14M204.53M162.43M
Depreciation & Amortization355.87K1.09M6.6M9.49M7.31M
EBITDA(57.94M)(38.6M)(8.21M)(6.65M)(1.52M)
EBITDA Margin-62.4%-32.4%-5.4%-3.1%-0.8%
Operating Income(54.3M)(43.45M)(14.49M)(16.14M)(7.67M)
Operating Margin-58.5%-36.5%-9.5%-7.6%-4.0%
Interest Income00000
Interest Expense3.02M1.28M2.6M2.18M1.36M
Other Income / Expenses(7.02M)(1.21M)(2.92M)(2.18M)(2.52M)
Income Before Tax(61.32M)(44.66M)(17.41M)(18.33M)(10.19M)
Pre-Tax Margin-66.0%-37.5%-11.4%-8.6%-5.2%
Income Tax Expense7.7K360.7K428K402K45.72K
Net Income(60.9M)(45.54M)(20.6M)(18.88M)(7.11M)
Net Margin-65.6%-38.3%-13.5%-8.9%-3.7%
EPS (Basic)(2.27)(1.57)(0.70)(0.53)(0.23)
EPS (Diluted)(2.27)(1.57)(0.70)(0.53)(0.23)
Weighted Avg Shares27.01M30.98M33.91M41.2M45.13M
Weighted Avg Shares (Diluted)27.01M30.98M33.91M41.2M45.13M

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.